SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001358403-19-000010
Filing Date
2019-01-04
Accepted
2019-01-04 16:04:19
Documents
1
Period of Report
2018-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_154663584165870.html 3  
1 FORM 3 wf-form3_154663584165870.xml 3 14895
  Complete submission text file 0001358403-19-000010.txt   16382
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2130 W. HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address
Williams Rosemary Y. (Reporting) CIK: 0001747727 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 19510000